Summary: Vivos Therapeutics’ pilot study showed that 79% of newly diagnosed obstructive sleep apnea (OSA) patients preferred oral appliance therapy over CPAP. The study, conducted in multiple dental and ENT offices over seven months, involved 99 patients and demonstrated high … [Read more...]